AVECHO BIOTECHNOLOGY LIMITED

0.00%

0.5¢

Market Cap $15.86M

Healthcare Biotechnology

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company... Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM. More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag

Subject

AVE

Ann: Phase III Insomnia Trial Recruitment Update

30/07/25

2.0K

30/07/25

Last post FrankieAlfie

2.0K

AVE

Ann: June 2025 Quarterly Activities Report & Appendix 4C

30/07/25

448

30/07/25

Last post kingkev

448

AVE

Recent Media

28/07/25

10K

28/07/25

Last post FrankieAlfie

10K

AVE

teenage skin care

23/07/25

1.5K

23/07/25

Last post Virgon

1.5K

AVE

Ann: Change in Substantial Holding

25/06/25

460

25/06/25

Last post

ASX News

460

AVE

Where’d Everybody go?

18/06/25

3.2K

18/06/25

Last post Bodi

3.2K

AVE

Ann: Receipt of R&D Tax Incentive

02/06/25

6.3K

02/06/25

Last post JamesPender

6.3K

AVE

Ann: Change of Director's Interest Notice x4

27/05/25

347

27/05/25

Last post

ASX News

347

See All Discussions

Timeline

June 2025 Quarterly Activities Report & Appendix 4C
30 Jul 08:44	Share

Phase III Insomnia Trial Recruitment Update
29 Jul 09:08	Share

Change in Substantial Holding
25 Jun 09:25	Share

Receipt of R&D Tax Incentive
28 May 11:24	Share

Change of Director's Interest Notice x4
27 May 15:02	Share

Notification regarding unquoted securities - AVE
27 May 14:53	Share

2025 Annual General Meeting Results
27 May 14:47	Share

Chair's Address and CEO Presentation
27 May 12:28	Share

Phase III Trial Update - New Sites Commence Recruitment
20 May 09:02	Share

March 2025 Quarterly Activities Report & Appendix 4C
30 Apr 10:07	Share

Notice of Annual General Meeting/Proxy Form
24 Apr 08:26	Share

Application for quotation of securities - AVE
16 Apr 15:56	Share

Section 708A Cleansing Statement
16 Apr 15:54	Share

Avecho receives initial US$3M upfront payment from Sandoz
28 Mar 09:21	Share

Avecho to present at NWR Virtual Healthcare Conference
13 Mar 08:43	Share

Appendix 4G and Corporate Governance Statement
07 Mar 12:11	Share

Annual Report 31 December 2024
07 Mar 12:07	Share

Licensing Webinar and Presentation
04 Mar 10:23	Share

Avecho & Sandoz Sign Deal to Develop CBD for Insomnia in AUS
03 Mar 09:46	Share

Trading Halt
28 Feb 08:53	Share

Appendix 4E - Preliminary Final Report
28 Feb 08:29	Share

Response to ASX Price Query
14 Feb 13:11	Share

December 2024 Quarterly Activities Report & Appendix 4C
30 Jan 16:21	Share

Change of Director's Interest Notice x3
02 Dec 10:02	Share

Notification of cessation of securities - AVE
02 Dec 09:58	Share

September 2024 Quarterly Activities Report & Appendix 4C
29 Oct 09:34	Share

Appendix 4D and Half-year Financial Report
26 Aug 11:22	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $15.86M

Open	High	Low	Value	Volume
0.5¢	0.6¢	0.4¢	$28.1K	5.620M

Buyers (Bids)

No.	Vol.	Price($)
43	40990100	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	450000	1

View Market Depth

No.	Vol.	Price($)
43	40990100	0.004
29	19036683	0.003
14	12197700	0.002
14	63799989	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	450000	1
0.006	8378607	11
0.007	4858187	15
0.008	6092737	6
0.009	2143333	4

Last trade - 15.47pm 31/07/2025 (20 minute delay)


Last 0.5¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
0.5¢	0.5¢	0.5¢	1342134
Last updated 14.40pm 31/07/2025 ?

AVE (ASX) Chart

AVECHO BIOTECHNOLOGY LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Avecho Biotechnology (ASX:AVE) expands clinical CBD program with the Lambert Initiative

22 Feb 2023 11:35 (AEDT)

Latest Articles

Avecho clocks $4.7M payment from pharma giant Sandoz for CBD capsule licence

Avecho (ASX:AVE) has received a US$3M (A$4.7M) payment from pharma heavyweight Sandoz in exchange for the latter's right to use Avecho's licence for a CBD capsule sleeping pill.

Avecho Biotechnology (ASX:AVE) passes "crucial" two-year stability milestone for CBD capsule

Avecho Biotechnology (ASX:AVE) has passed a "crucial" two-year stability milestone for its TPM-enhanced cannabidiol (CBD) soft-gel capsule.

Avecho Biotechnology (ASX:AVE) completes the development of proprietary TPM cannabinoid gummies

Avecho Biotechnology (ASX:AVE) has completed the development of its first-generation proprietary TPM gummies containing cannabinoids.

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

Featured News